Propranolol-induced postoperative hypertension following coronary artery bypass grafting.
Fifteen patients receiving propranolol preoperatively and undergoing coronary artery bypass grafting had serum propranolol levels determined preoperatively and at several times early postoperatively. In addition, the patients' hemodynamic parameters and postoperative sodium nitroprusside dose requirements were monitored. All patients had significant multivessel disease and normal left ventricular function. Preoperative serum propranolol levels ranged from 16 to 243 ng/ml, with a mean level of 92 +/- 17 ng/ml; propranolol measured at the end of bypass ranged from 0 to 92 ng/ml, with a mean level of 23 +/- 7 ng/ml. Fourteen patients (93%) had hypertension postoperatively and required intravenous sodium nitroprusside to maintain mean blood pressure at or below 90 mm Hg. According to linear regression analysis, the severity of the postoperative hypertension or, specifically, the nitroprusside dose requirements, correlated significantly with the patients' serum propranolol levels postoperatively (correlation coefficient, R = 0.76, with p less than 0.001). The one normotensive patient had no detectable serum propranolol at any time postoperatively. No correlation was noted between the patient's preoperative serum propranolol levels and the need for nitroprusside therapy postoperatively. These results demonstrate that there is a significant relationship between residual propranolol and the development of hypertension postoperatively.
D000328:Adult; D000368:Aged; D001026:Coronary Artery Bypass; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000008:administration & dosage; D011183:Postoperative Complications / Q000139:chemically induced; D011433:Propranolol / Q000009:adverse effects* / Q000097:blood
D009599:Nitroprusside; D011433:Propranolol